We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWRS icon
3126
Global Water Resources
GWRS
$219M
$142K ﹤0.01%
15,200
BX icon
3127
CALL
Blackstone
BX
$110B
$141K ﹤0.01%
78,900
+12,900
+20% +$420K
FATE icon
3128
Fate Therapeutics
FATE
$326M
$141K ﹤0.01%
+23,025
New +$103K
WMC
3129
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$141K ﹤0.01%
1,416
-50
-3% -$5.09K
DSE
3130
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$141K ﹤0.01%
2,408
+714
+42% +$41.2K
PFL
3131
PIMCO Income Strategy Fund
PFL
$388M
$140K ﹤0.01%
+12,003
New +$142K
TAHO
3132
DELISTED
Tahoe Resources Inc
TAHO
$139K ﹤0.01%
28,940
-148,713
-84% -$699K
MOBL
3133
DELISTED
MobileIron, Inc.
MOBL
$138K ﹤0.01%
35,412
-15,333
-30% -$59.2K
TRUE
3134
DELISTED
TrueCar
TRUE
$137K ﹤0.01%
12,250
-6,500
-35% -$85.6K
PVLA
3135
Palvella Therapeutics
PVLA
$2.27B
$137K ﹤0.01%
228
-25
-10% -$11.6K
AMPE
3136
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$137K ﹤0.01%
+112
New +$52.7K
NDP
3137
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$136K ﹤0.01%
+1,278
New +$131K
CDE icon
3138
Coeur Mining
CDE
$17.9B
$133K ﹤0.01%
+17,790
New +$140K
VOC icon
3139
VOC Energy
VOC
$51.9M
$133K ﹤0.01%
22,522
+3,462
+18% +$14.8K
BHC icon
3140
CALL
Bausch Health
BHC
$2.34B
$131K ﹤0.01%
30,000
-300
-1% -$4.76K
PNNT
3141
Pennant Park Investment Corp
PNNT
$241M
$131K ﹤0.01%
19,000
VWTR
3142
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$131K ﹤0.01%
+10,256
New +$164K
AGEN
3143
Agenus
AGEN
$290M
$130K ﹤0.01%
+2,038
New +$156K
BRID icon
3144
Bridgford Foods
BRID
$56.5M
$129K ﹤0.01%
+10,300
New +$131K
PSP icon
3145
Invesco Global Listed Private Equity ETF
PSP
$246M
$129K ﹤0.01%
2,072
-45
-2% -$2.84K
SAND
3146
DELISTED
Sandstorm Gold
SAND
$129K ﹤0.01%
25,860
+1,000
+4% +$4.53K
CMBT
3147
CMB.TECH NV
CMBT
$4.73B
$129K ﹤0.01%
13,900
AUY
3148
DELISTED
Yamana Gold, Inc.
AUY
$129K ﹤0.01%
41,479
+11,618
+39% +$31K
ESRX
3149
CALL
DELISTED
Express Scripts Holding Company
ESRX
$129K ﹤0.01%
23,900
-2,600
-10% -$166K
IID
3150
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$129K ﹤0.01%
17,148

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.